Saira Ramasastry sold $400K of Mirum Pharmaceuticals (MIRM)

Executed Dec 22 2025, disclosed Dec 23 2025, 1 day later.

Value, as filed

$400K

5,000 sh × $80.00

Executed

Dec 22 2025

the trade date, as filed

Disclosed

Dec 23 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Saira Ramasastry Director profile →

Saira Ramasastry (Director) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Mirum Pharmaceuticals, Inc. (MIRM). The largest single filing was $400K of MIRM (5,000 sh × $80.00, as filed), executed Dec 22 2025.

The name

MIRM

Mirum Pharmaceuticals, Inc. MIRM · Healthcare · 60 filings in 24 months ticker →

Healthcare · Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitat…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Saira Ramasastry in MIRM

MIRMSALE Mirum Pharmaceuticals, Inc. $398K
3,977 sh × $100.00
Exec Jun 1
Filed Jun 2 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. $219K
2,000 sh × $109.47
Exec May 15
Filed May 18 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. $194K
2,000 sh × $96.90
Exec Apr 15
Filed Apr 16 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. $182K
2,000 sh × $90.76
Exec Mar 16
Filed Mar 17 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. $204K
2,000 sh × $102.09
Exec Feb 13
Filed Feb 17 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. $182K
2,000 sh × $90.99
Exec Jan 15
Filed Jan 16 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. $1.3M
as filed
Exec Sep 8 2025
Filed Sep 10 2025 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. $378K
8,203 sh across 2 lots
Exec Jun 2 2025
Filed Jun 4 2025 · 5:30 PM ET